The American Academy of Orthopaedic Surgeons (AAOS) has announced the inaugural Arnold I. Caplan Award for Distinguished Research in Orthobiologics, a significant accolade honoring the groundbreaking work in stem cell research and its applications in orthobiologics.
Named after Dr. Arnold Caplan, a visionary often regarded as the “godfather of Medicinal Signaling Cells (MSCs),” this award recognizes those who have made substantial contributions to advancing biologic solutions for musculoskeletal injuries.
Dr. Caplan’s pioneering research in stem cell biology has paved the way for innovative treatments that have the potential to transform patient outcomes in orthopedics. His legacy continues through this award, which aims to inspire the next generation of scientific explorers dedicated to pushing the boundaries of stem cell science and its clinical applications.
The award, established through the generosity of the Caplan family, will be presented annually, with the first recipient being recognized at the AAOS 2025 Annual Meeting in San Diego. This prestigious honor includes a cash prize of $10,000, further encouraging innovative research in the field of stem cell and orthobiologics.
By fostering excellence in stem cell research, the Caplan Award not only celebrates Dr. Caplan’s legacy but also ensures continued progress in the development of biologic solutions that can improve musculoskeletal health worldwide.
This announcement underscores the importance of stem cell research in the future of orthopedics and highlights the ongoing commitment of the AAOS to advancing musculoskeletal health through evidence-based education and research.
To view the award criteria or submit an application, click here.